NCT04065594

Brief Summary

Background Chronic non-healing ulcer is a common problem met in clinical practice and represents a burden to the patients. Chronic ulcer lacks growth factors (GFs) to promote the healing process and is frequently followed by superadded infections. Ordinary technique such as wound debridement and regular dressings cannot provide adequate results as these techniques cannot provide the necessary GFs. Platelet-rich plasma (PRP) helps wound healing by releasing various types of GFs. The aim: to evaluate and compare the efficacy of PRP dressing versus traditional dressings in the treatment of chronic non-healing leg and foot ulcers of different etiology as regard cost of overall treatment and effectiveness (reduction of the size of the ulcer and safety of the technique). Methods This prospective study was performed on inpatients and outpatients in general surgery department, Zagazig university hospital from June 2017 to January 2019. Patients were divided randomly into two groups: group A received PRP dressing (N=22, 50%) and group B received conventional ordinary dressing (N=22, 50%).The mean follow-up period was 3 months after the last dressing. Patients treated with PRP at once-weekly interval for a maximum of 12 dressings while patients with ordinary dressings may need one dressing every other day for a maximum of 12 weeks. The reduction in the size of the ulcers (area and volume) in both groups was assessed using centimeter scale and Digital photographs before and after each session and during follow up period. Keywords: Platelet-rich plasma, ulcers, non-healing, ordinary dressing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 22, 2019

Completed
Last Updated

August 22, 2019

Status Verified

August 1, 2019

Enrollment Period

1.6 years

First QC Date

August 12, 2019

Last Update Submit

August 21, 2019

Conditions

Keywords

ulcersplatelet rich plasmaordinary dressingnon-healing

Outcome Measures

Primary Outcomes (1)

  • change the ulcer size

    healing of the ulcer is assessed using centimeter scale before each dressing

    1.8 years

Study Arms (2)

PRP dressing

EXPERIMENTAL
Procedure: PRP dressing

conventional ordinary dressing

EXPERIMENTAL
Procedure: conventional ordinary dressing

Interventions

PRP dressingPROCEDURE

PRP dressing gel dressings for treatment of chronic ulcer

PRP dressing

conventional ordinary dressing for treatment of chronic ulcer

conventional ordinary dressing

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old,
  • males and non-pregnant females,
  • hemoglobin (\> 10 gm. /dL),
  • post-prandial blood sugar ≤ 140 mg% if diabetic,
  • Wounds free of infection (sterile swab) or necrosis.

You may not qualify if:

  • malignant ulcer(by biopsy),
  • pus discharge/slough,
  • ulcer with exposed tendons/ligaments/bone,
  • ischemic ulcer (by duplex U/S),
  • non-compliant patients ,
  • radiation near to the site of ulcer,
  • osteomyelitis of underlying bone (x-ray-bone scan) ,
  • steroids therapy ,
  • thrombocytopenia(\< 150,000/dl)
  • patients unfit or refuse blood donation from himself or from others.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tamer Alsaied Alnaimy

Zagazig, Sharqia Province, 055, Egypt

Location

MeSH Terms

Conditions

Foot UlcerUlcer

Condition Hierarchy (Ancestors)

Foot DiseasesSkin DiseasesSkin and Connective Tissue DiseasesLeg UlcerSkin UlcerPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • tamer A Alnaimy, MD

    faculty of medicine Zagazig university

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical professour

Study Record Dates

First Submitted

August 12, 2019

First Posted

August 22, 2019

Study Start

June 1, 2017

Primary Completion

January 1, 2019

Study Completion

April 1, 2019

Last Updated

August 22, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations